NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 305 filers reported holding NOVOCURE LTD in Q3 2022. The put-call ratio across all filers is 1.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $278,000 | +5.7% | 4,149 | +31.9% | 0.06% | +5.0% |
| Q1 2022 | $263,000 | -67.2% | 3,146 | -70.6% | 0.06% | -57.4% |
| Q4 2021 | $802,000 | +202.6% | 10,694 | +345.4% | 0.14% | +88.0% |
| Q3 2021 | $265,000 | -76.8% | 2,401 | -72.0% | 0.08% | -67.1% |
| Q1 2021 | $1,143,000 | +83.8% | 8,575 | +84.4% | 0.23% | -3.8% |
| Q3 2020 | $622,000 | +6.9% | 4,650 | -54.0% | 0.24% | +62.3% |
| Q2 2020 | $582,000 | -2.3% | 10,100 | +34.4% | 0.15% | -7.6% |
| Q4 2019 | $596,000 | – | 7,517 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $24,386,000 | 14.72% |
| HARTLINE INVESTMENT CORP/ | 335,191 | $58,001,000 | 8.32% |
| Deep Track Capital, LP | 1,341,300 | $93,220,000 | 6.13% |
| MORGAN JESS S & CO INC | 48,345 | $3,360,000 | 3.48% |
| Taylor Frigon Capital Management LLC | 68,908 | $4,789,000 | 2.49% |
| HighVista Strategies LLC | 28,007 | $1,946,000 | 1.18% |
| Private Harbour Investment Management & Counsel, LLC | 13,106 | $911,000 | 1.01% |
| Lloyd Park, LLC | 9,325 | $648,000 | 0.68% |
| Baillie Gifford | 9,116,230 | $633,578,000 | 0.65% |
| HAP Trading, LLC | 110,900 | $10,575,000 | 0.53% |